Berlin
Germany
98
2015-01-01
86
2014-07-08
These are the the leading inventors for applications assigned to Bayer Schering Pharma AG:
Bayer Schering Pharma AG based in Berlin, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PROCESS FOR THE PREPARATION OF 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS
#2 | 2013-03-07 β Patent 8,772,511 granted on 2014-07-08Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
#3 | 2013-01-03 β Patent 8,680,117 granted on 2014-03-255-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
#4 | 2012-10-112-HETEROARYL CARBOXAMIDES
#5 | 2012-08-09 β Patent 8,884,017 granted on 2014-11-112-heteroarylcarboxylic acid amides
#6 | 2011-10-272-HETEROARYL CARBOXAMIDES
#7 | 2011-09-08 β Patent 8,574,594 granted on 2013-11-05Generation of replication competent viruses for therapeutic use
#8 | 2011-06-23 β Patent 8,466,280 granted on 2013-06-18Co-crystal compound of rivaroxaban and malonic acid
#9 | 2011-05-05 β Patent 9,126,025 granted on 2015-09-08Method of coating a folded catheter balloon
#10 | 2011-01-18 β Patent 7,871,994 granted on 2011-01-18Hormone replacement therapy method and its administration form
#11 | 2011-01-13PHARMACEUTICAL PREPARATION CONTAINING A GESTAGEN, AND KIT AND METHOD FOR TREATING ENDOMETRIOSIS USING THE PREPARATION
#12 | 2010-12-23 β Patent 8,153,799 granted on 2012-04-10Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
#13 | 2010-11-1817BETA-CYANO-19-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE
#14 | 2010-11-18NOVEL [F-18]-LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), THEIR USE AND PROCESSES FOR THEIR PREPARATION
#15 | 2010-09-30 β Patent 7,935,827 granted on 2011-05-03Optically active, heteroaromatic Ξ²-hydroxy esters and processes for their preparation from Ξ²-keto esters and processes for the preparation of these Ξ²-keto esters
#16 | 2010-09-21 β Patent 7,799,770 granted on 2010-09-21Solid body forms of mesoprogestin 11Ξ²-{4E-(hydroxyiminomethyl)-phenyl}-17Ξ± methoxymethyl-17Ξ²-methoxy-estra-4,9-dien-3-one
#17 | 2010-09-02 β Patent 8,076,355 granted on 2011-12-132-heteroarylcarboxylic acid amides
#18 | 2010-06-10Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypertension
#19 | 2010-06-03 β Patent 8,129,378 granted on 2012-03-06Substituted oxazolidinones and their use in the field of blood coagulation
#20 | 2010-06-03 β Patent 8,216,819 granted on 2012-07-10Generation of oncolytic adenoviruses and uses thereof
#21 | 2010-04-08 β Patent 8,211,930 granted on 2012-07-03Phenyl and benzodioxinyl substituted indazoles derivatives
#22 | 2010-03-18Regulation of Human Transmembrane Serine Protease
#23 | 2010-03-11 β Patent 7,730,628 granted on 2010-06-08Depth stop devices and systems
#24 | 2010-03-04 β Patent 7,973,166 granted on 2011-07-05N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
#25 | 2010-02-04Extended Benzamide Derivatives as Modulators of the EP2 Receptor
#26 | 2009-11-12USE OF A VIRUS REGIMEN FOR THE TREATMENT OF DISEASES
#27 | 2009-10-20 β Patent 7,605,136 granted on 2009-10-20Effector conjugates, methods for their preparation and their pharmaceutical use
#28 | 2009-09-24 β Patent 9,233,176 granted on 2016-01-12Systems and method of delivering fluids to a patient of varying concentration
#29 | 2009-09-10 β Patent 8,158,599 granted on 2012-04-17Chimeric adenoviruses for use in cancer treatment
#30 | 2009-09-10 β Patent 8,003,787 granted on 2011-08-23Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
#31 | 2009-08-20ANTI-TUMOR EFFECTIVE PARAMYXOVIRUS
#32 | 2009-08-13 β Patent 8,148,411 granted on 2012-04-032-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
#33 | 2009-07-23 β Patent 7,863,283 granted on 2011-01-04Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
#34 | 2009-07-16 β Patent 7,622,292 granted on 2009-11-24Regulation of human transmembrane serine protease
#35 | 2009-06-25 β Patent 8,267,886 granted on 2012-09-18Catheter having a core wire and a low profile bond
#36 | 2009-06-16 β Patent 7,547,721 granted on 2009-06-16Near infrared fluorescent contrast agent and fluorescence imaging
#37 | 2009-06-11 β Patent 7,897,626 granted on 2011-03-012-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
#38 | 2009-05-28 β Patent 7,776,864 granted on 2010-08-17Fused bicyclic pyrimidines
#39 | 2009-04-09 β Patent 8,008,325 granted on 2011-08-30Plasma carboxypeptidase B inhibitors
#40 | 2009-03-26 β Patent 7,806,861 granted on 2010-10-05Closure piece for medical syringe
#41 | 2009-02-12 β Patent 7,987,986 granted on 2011-08-02Device and use for storage and provision of medicament wafers
#42 | 2009-01-29 β Patent 7,977,325 granted on 2011-07-123-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
#43 | 2009-01-15 β Patent 7,825,114 granted on 2010-11-02Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
#44 | 2009-01-08 β Patent 7,850,948 granted on 2010-12-14Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
#45 | 2008-10-16 β Patent 7,820,664 granted on 2010-10-26Inhibitors of MEK
#46 | 2008-08-21 β Patent 7,902,178 granted on 2011-03-08Progesterone receptor antagonists
#47 | 2008-08-05 β Patent 7,407,975 granted on 2008-08-05Epothilone derivatives, method for producing same and their pharmaceutical use
#48 | 2008-07-03 β Patent 8,263,040 granted on 2012-09-11Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
#49 | 2008-06-26 β Patent 7,846,917 granted on 2010-12-0718-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
#50 | 2008-06-17 β Patent 7,388,006 granted on 2008-06-17Non-steroidal progesting
#51 | 2008-05-08 β Patent 7,598,263 granted on 2009-10-06Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
#52 | 2008-04-17 β Patent 7,576,111 granted on 2009-08-18Substituted oxazolidinones and their use in the field of blood coagulation
#53 | 2008-04-10 β Patent 7,910,573 granted on 2011-03-22Crystalline forms of 11Ξ²-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17Ξ±-pregna-4,9-dien-3-one
#54 | 2008-03-13 β Patent 7,795,264 granted on 2010-09-14Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
#55 | 2008-03-13 β Patent 8,003,655 granted on 2011-08-23Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
#56 | 2008-03-06 β Patent 7,943,629 granted on 2011-05-17Sulphimides as protein kinase inhibitors
#57 | 2008-03-06 β Patent 7,846,928 granted on 2010-12-07Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
#58 | 2008-02-07 β Patent 7,999,108 granted on 2011-08-16Benzyl amines, a process for their production and their use as anti-inflammatory agents
#59 | 2007-12-25 β Patent 7,312,225 granted on 2007-12-25Macrocyclic pyrimidines, their production and use as pharmaceutical agents
#60 | 2007-11-15 β Patent 7,723,544 granted on 2010-05-25Process for recovery of iopromide, suitable for pharmaceutical purposes, from mother liquors
#61 | 2007-11-06 β Patent 7,291,624 granted on 2007-11-06CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
#62 | 2007-10-04 β Patent 7,825,128 granted on 2010-11-02Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
#63 | 2007-10-04 β Patent 7,449,459 granted on 2008-11-11Inhibitors of soluble adenylate cyclase
#64 | 2007-09-27 β Patent 7,880,042 granted on 2011-02-01Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics
#65 | 2007-09-06 β Patent 7,879,853 granted on 2011-02-014,6-disubstituted pyrimidines and their use as protein kinase inhibitors
#66 | 2007-08-02Modulation of MDL-1 activity for treatment of inflammatory disease
#67 | 2007-07-31 β Patent 7,250,408 granted on 2007-07-31Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
#68 | 2007-07-31 β Patent 7,250,168 granted on 2007-07-31Tissue factor targeted thrombomodulin fusion proteins as anticoagulants
#69 | 2007-07-12 β Patent 7,806,262 granted on 2010-10-05Container
#70 | 2007-06-28 β Patent 7,473,709 granted on 2009-01-0611Ξ²-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones
#71 | 2007-05-10 β Patent 7,994,346 granted on 2011-08-09Intermediates for the preparation of lipoxin Aanalogs
#72 | 2007-04-26 β Patent 7,750,000 granted on 2010-07-06Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
#73 | 2007-04-26 β Patent 7,569,557 granted on 2009-08-04Compositions of estrogen-cyclodextrin complexes
#74 | 2007-04-24 β Patent 7,208,283 granted on 2007-04-24Methods for determining hormonal effects of substances using Ewing sarcoma protein and androgen receptor
#75 | 2007-03-15 β Patent 7,879,314 granted on 2011-02-01Optical imaging of rheumatoid arthritis
#76 | 2007-01-25 β Patent 7,319,154 granted on 2008-01-15Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
#77 | 2007-01-25 β Patent 7,601,748 granted on 2009-10-13Anti-androgenic pyrrolidines with tumor-inhibiting action
#78 | 2006-11-23 β Patent 7,572,794 granted on 2009-08-11Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
#79 | 2006-11-09 β Patent 7,842,809 granted on 2010-11-30Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
#80 | 2006-07-27 β Patent 7,579,000 granted on 2009-08-25Tissue factor targeted antibodies as anticoagulants
#81 | 2006-07-20 β Patent 7,906,533 granted on 2011-03-15Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
#82 | 2006-07-13 β Patent 7,538,205 granted on 2009-05-26Regulation of human prostasin-like serine protease
#83 | 2006-07-06 β Patent 7,626,035 granted on 2009-12-01Optically active, heteroaromatic Ξ²-hydroxy esters and processes for their preparation from Ξ²-keto esters and processes for the preparation of these Ξ²-keto esters
#84 | 2006-06-08 β Patent 7,550,296 granted on 2009-06-23Generation of replication competent viruses for therapeutic use
#85 | 2006-06-01 β Patent 7,902,229 granted on 2011-03-08Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
#86 | 2006-03-16 β Patent 8,491,906 granted on 2013-07-23Selective targeting of tumor vasculature using antibody molecules
#87 | 2005-12-08 β Patent 7,659,297 granted on 2010-02-09Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#88 | 2005-12-08 β Patent 7,368,568 granted on 2008-05-06Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
#89 | 2005-12-01 β Patent 7,358,382 granted on 2008-04-15Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production
#90 | 2005-08-04 β Patent 7,662,821 granted on 2010-02-16Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#91 | 2005-06-16 β Patent 7,388,003 granted on 2008-06-17Ξ-D-Homosteroids with androgenic action
#92 | 2005-05-05 β Patent 7,786,101 granted on 2010-08-31Cardiovascular protection using anti-aldosteronic progestins
#93 | 2005-04-28 β Patent 7,262,023 granted on 2007-08-28Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof
#94 | 2005-04-07 β Patent 7,361,645 granted on 2008-04-22Androgenic 7-substituted 11-halogen steroids
#95 | 2005-03-10 β Patent 7,517,894 granted on 2009-04-14VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
#96 | 2005-02-10 β Patent 7,718,640 granted on 2010-05-18Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
#97 | 2005-02-03 β Patent 7,550,451 granted on 2009-06-23Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy
#98 | 2005-01-06 β Patent 7,879,357 granted on 2011-02-01Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
12952 β